-
Cost-Effectiveness Analysis of Serplulimab Combined with Nab-Paclitaxel Plus Carboplatin Compared to Nab-Paclitaxel Plus Carboplatin Alone as First-Line Treatment for Advanced Squamous Non-Small Cell Lung Cancer in China
14 Apr 2025 14:59 GMT
… diagnosed lung cancer cases and 766,898 lung cancer-related … lung cancer (NSCLC) accounts for the majority (80% - 85%) of all lung cancers … plus platinum and gemcitabine as first-line … lung cancer: a cost-effectiveness analysis. Translational Lung Cancer Res …
-
EU approves AstraZeneca's Imfinzi─in combo with chemotherapy to treat patients with resectable non─small cell lung cancer
05 Apr 2025 07:44 GMT
… Lung cancer is broadly split into NSCLC and small cell lung cancer … combination with chemotherapy (gemcitabine plus cisplatin) in … portfolio includes leading lung cancer medicines and the … improvements for people with lung cancer, including and beyond …
-
Exploring Protein Expression Profiles in Lung Cancer Insufficient Microwave Ablation: Implications for Recurrence
02 Apr 2025 16:42 GMT
… changes in human lung cancer. Human lung tumor tissues post-recurrence … I non-small cell lung cancers: long-term results. … after microwave ablation of lung tumors: a retrospective study … ribonucleotide reductase inactivation by gemcitabine. Chemistry. 2007;13( …
-
Bristol Myers Squibb Receives Positive CHMP Opinion for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Opdivo for Resectable Non-Small Cell Lung Cancer in Patients with Tumor Cell PD-L1...
28 Mar 2025 13:11 GMT
… of four tumor types: lung cancer, bladder cancer, esophageal … pathologic response.
About Lung Cancer
Lung cancer is the leading … combination with cisplatin and gemcitabine, is indicated as … lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
EU approves AstraZeneca's Imfinzi as monotherapy to treat adults with limited─stage small cell lung cancer
18 Mar 2025 13:14 GMT
… limited-stage small cell lung cancer (LS-SCLC) whose … in combination with chemotherapy (gemcitabine plus cisplatin) in … portfolio includes leading lung cancer medicines and the … improvements for people with lung cancer, including and beyond treatment …
-
EMA committee recommends approval of AstraZeneca's Imfinzi in combo with chemotherapy to treat resectable non─small cell lung cancer
04 Mar 2025 07:39 GMT
… Lung cancer is broadly split into NSCLC and small cell lung cancer … combination with chemotherapy (gemcitabine plus cisplatin) in … portfolio includes leading lung cancer medicines and the … improvements for people with lung cancer, including and beyond …
-
Bristol Myers Squibb Announces Opdivo® Plus Chemotherapy as the First and Only Neoadjuvant-Only Immuno-Oncology Therapy to Demonstrate Statistically Significant and Clinically Meaningful Overall Survival in Resectable Non-Small Cell Lung Cancer
19 Feb 2025 12:09 GMT
… positive) non-small cell lung cancer (NSCLC).
OPDIVO® (nivolumab … combination with cisplatin and gemcitabine, is indicated as … metastatic non-small cell lung cancer, in combination with … cell lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
Metabolomic Analysis, Antiproliferative, Anti-Migratory, and Anti-Invasive Potential of Amlodipine in Lung Cancer Cells
19 Feb 2025 00:32 GMT
… lung cancer (NSCLC) forms approximately 80% of all lung cancer … regimens, in combination with gemcitabine, paclitaxel, or pemetrexed, … with amlodipine.
Discussion
Lung cancer, specifically NSCLC, continues … pathway after treating lung cancer cells A549 with …
-
Imfinzi recommended for approval in European Union for the treat of adults with limited-stage small cell lung cancer
04 Feb 2025 22:22 GMT
… limited-stage small cell lung cancer. If approved, these … in combination with chemotherapy (gemcitabine plus cisplatin) in … portfolio includes leading lung cancer medicines and the … improvements for people with lung cancer, including and beyond treatment …
-
Drug-Eluting Beads Bronchial Arterial Chemoembolization Combined with Immunotherapy Resulted in Pathological Complete Response of Squamous Cell Lung Cancer: A Case Report
18 Dec 2024 16:06 GMT
… candidate drug for treating lung cancer. Importantly, epirubicin … arterial chemoembolization in lung cancer patients with hemoptysis. … pathologic assessment of lung cancer resection specimens after … gemcitabine for treatment of non-small cell lung cancer. …
About
© 1995-2025